These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


221 related items for PubMed ID: 27865391

  • 1. Modulation of dendritic cell and monocyte subsets in tuberculosis-diabetes co-morbidity upon standard tuberculosis treatment.
    Kumar NP, Moideen K, Sivakumar S, Menon PA, Viswanathan V, Kornfeld H, Babu S.
    Tuberculosis (Edinb); 2016 Dec; 101():191-200. PubMed ID: 27865391
    [Abstract] [Full Text] [Related]

  • 2. Profiling leucocyte subsets in tuberculosis-diabetes co-morbidity.
    Kumar NP, Moideen K, Dhakshinraj SD, Banurekha VV, Nair D, Dolla C, Kumaran P, Babu S.
    Immunology; 2015 Oct; 146(2):243-50. PubMed ID: 26095067
    [Abstract] [Full Text] [Related]

  • 3. Effect of standard tuberculosis treatment on naive, memory and regulatory T-cell homeostasis in tuberculosis-diabetes co-morbidity.
    Kumar NP, Moideen K, Viswanathan V, Kornfeld H, Babu S.
    Immunology; 2016 Sep; 149(1):87-97. PubMed ID: 27289086
    [Abstract] [Full Text] [Related]

  • 4. Undernutrition is associated with perturbations in T cell-, B cell-, monocyte- and dendritic cell- subsets in latent Mycobacterium tuberculosis infection.
    Rajamanickam A, Munisankar S, Dolla CK, Babu S.
    PLoS One; 2019 Sep; 14(12):e0225611. PubMed ID: 31821327
    [Abstract] [Full Text] [Related]

  • 5. Elevated circulating levels of monocyte activation markers among tuberculosis patients with diabetes co-morbidity.
    Kumar NP, Moideen K, Bhootra Y, Nancy A, Viswanathan V, Shruthi BS, Sivakumar S, Natarajan M, Kornfeld H, Babu S.
    Immunology; 2019 Mar; 156(3):249-258. PubMed ID: 30427060
    [Abstract] [Full Text] [Related]

  • 6. Diabetes mellitus and tuberculosis: pattern of tuberculosis, two-month smear conversion and treatment outcomes in Guangzhou, China.
    Mi F, Tan S, Liang L, Harries AD, Hinderaker SG, Lin Y, Yue W, Chen X, Liang B, Gong F, Du J.
    Trop Med Int Health; 2013 Nov; 18(11):1379-85. PubMed ID: 24112411
    [Abstract] [Full Text] [Related]

  • 7. Association between pulmonary tuberculosis and Type 2 diabetes in Sudanese patients.
    Ahmed M, Omer I, Osman SM, Ahmed-Abakur EH.
    Int J Mycobacteriol; 2017 Nov; 6(1):97-101. PubMed ID: 28317813
    [Abstract] [Full Text] [Related]

  • 8. Type 2 diabetes - Tuberculosis co-morbidity is associated with diminished circulating levels of IL-20 subfamily of cytokines.
    Kumar NP, Banurekha VV, Nair D, Kumaran P, Dolla CK, Babu S.
    Tuberculosis (Edinb); 2015 Dec; 95(6):707-712. PubMed ID: 26354610
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.
    Banu Rekha VV, Balasubramanian R, Swaminathan S, Ramachandran R, Rahman F, Sundaram V, Thyagarajan K, Selvakumar N, Adhilakshmi AR, Iliayas S, Narayanan PR.
    Indian J Med Res; 2007 Nov; 126(5):452-8. PubMed ID: 18160750
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Type 2 diabetes mellitus is associated with altered CD8(+) T and natural killer cell function in pulmonary tuberculosis.
    Kumar NP, Sridhar R, Nair D, Banurekha VV, Nutman TB, Babu S.
    Immunology; 2015 Apr; 144(4):677-86. PubMed ID: 25363329
    [Abstract] [Full Text] [Related]

  • 14. Differential Frequencies of Intermediate Monocyte Subsets Among Individuals Infected With Drug-Sensitive or Drug-Resistant Mycobacterium tuberculosis.
    Sampath P, Natarajan AP, Moideen K, Kathamuthu GR, Hissar S, Dhanapal M, Jayabal L, Ramesh PM, Tripathy SP, Ranganathan UD, Babu S, Bethunaickan R.
    Front Immunol; 2022 Apr; 13():892701. PubMed ID: 35911760
    [No Abstract] [Full Text] [Related]

  • 15. Helminth species specific expansion and increased TNF-alpha production of non-classical monocytes during active tuberculosis.
    Bewket G, Kiflie A, Abate E, Stendahl O, Schön T, Blomgran R.
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009194. PubMed ID: 33651797
    [Abstract] [Full Text] [Related]

  • 16. Type 2 diabetes mellitus coincident with pulmonary or latent tuberculosis results in modulation of adipocytokines.
    Pavan Kumar N, Nair D, Banurekha VV, Dolla C, Kumaran P, Sridhar R, Babu S.
    Cytokine; 2016 Mar; 79():74-81. PubMed ID: 26771473
    [Abstract] [Full Text] [Related]

  • 17. Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes.
    Mily A, Sarker P, Taznin I, Hossain D, Haq MA, Kamal SMM, Agerberth B, Brighenti S, Raqib R.
    BMC Infect Dis; 2020 Dec 07; 20(1):933. PubMed ID: 33287713
    [Abstract] [Full Text] [Related]

  • 18. Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients.
    Singla R, Khan N, Al-Sharif N, Ai-Sayegh MO, Shaikh MA, Osman MM.
    Int J Tuberc Lung Dis; 2006 Jan 07; 10(1):74-9. PubMed ID: 16466041
    [Abstract] [Full Text] [Related]

  • 19. Heightened circulating levels of antimicrobial peptides in tuberculosis-Diabetes co-morbidity and reversal upon treatment.
    Kumar NP, Moideen K, Viswanathan V, Sivakumar S, Menon PA, Kornfeld H, Babu S.
    PLoS One; 2017 Jan 07; 12(9):e0184753. PubMed ID: 28910369
    [Abstract] [Full Text] [Related]

  • 20. Plasma Eicosanoid Levels in Tuberculosis and Tuberculosis-Diabetes Co-morbidity Are Associated With Lung Pathology and Bacterial Burden.
    Pavan Kumar N, Moideen K, Nancy A, Viswanathan V, Shruthi BS, Shanmugam S, Hissar S, Kornfeld H, Babu S.
    Front Cell Infect Microbiol; 2019 Jan 07; 9():335. PubMed ID: 31632923
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.